These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Bagga A, Hari P, Moudgil A, Jordan SC. Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181 [Abstract] [Full Text] [Related]
26. Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome. Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS. Pediatr Nephrol; 2017 Aug; 32(8):1377-1382. PubMed ID: 28341877 [Abstract] [Full Text] [Related]
27. Behavioural abnormalities in children with nephrotic syndrome. Mishra OP, Basu B, Upadhyay SK, Prasad R, Schaefer F. Nephrol Dial Transplant; 2010 Aug; 25(8):2537-41. PubMed ID: 20200003 [Abstract] [Full Text] [Related]
28. Use of a low-dose prednisolone regimen to treat a relapse of steroid-sensitive nephrotic syndrome in children. Raja K, Parikh A, Webb H, Hothi D. Pediatr Nephrol; 2017 Jan; 32(1):99-105. PubMed ID: 27677978 [Abstract] [Full Text] [Related]
29. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome. Nakahata T, Tanaka H, Tsugawa K, Kudo M, Suzuki K, Ito E, Waga S. Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896 [Abstract] [Full Text] [Related]
30. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators. Kurathong P, Jesdapatarakul S. J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687 [Abstract] [Full Text] [Related]
32. Bone age delay patterns in Legg-Calvé-Perthes disease: an analysis using the Tanner and Whitehouse 3 method. Lee ST, Vaidya SV, Song HR, Lee SH, Suh SW, Telang SS. J Pediatr Orthop; 2007 Mar; 27(2):198-203. PubMed ID: 17314646 [Abstract] [Full Text] [Related]
34. The correlation between attention deficit hyperactivity disorder and steroid-dependent nephrotic syndrome. Yousefichaijan P, Salehi B, Rafiei M, Dahmardnezhad M, Naziri M. Saudi J Kidney Dis Transpl; 2015 Nov; 26(6):1205-9. PubMed ID: 26586060 [Abstract] [Full Text] [Related]
36. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome. Mishra OP, Thakur N, Mishra RN, Prasad R. J Nephrol; 2012 Nov; 25(3):394-400. PubMed ID: 21928226 [Abstract] [Full Text] [Related]
37. Follow-up of linear growth of body height in children with nephrotic syndrome. Hung YT, Yang LY. J Microbiol Immunol Infect; 2006 Oct; 39(5):422-5. PubMed ID: 17066206 [Abstract] [Full Text] [Related]
38. Long-term results of two unconventional agents in steroid-dependent nephrotic children. Donia AF, Ammar HM, El-Agroudy Ael-B, Moustafa Fel-H, Sobh MA. Pediatr Nephrol; 2005 Oct; 20(10):1420-5. PubMed ID: 16047223 [Abstract] [Full Text] [Related]
39. Efficacy and safety of one year of growth hormone therapy in steroid-dependent nephrotic syndrome. Loke KY, Yap HK, Zhou X, Tan SP, Chao SM, Lee KO. J Pediatr; 1997 May; 130(5):793-9. PubMed ID: 9152290 [Abstract] [Full Text] [Related]
40. A short, intensive course of steroid therapy for nephrotic syndrome in Singapore children. Chuan PL. J Singapore Paediatr Soc; 1977 Dec; 19(4):242-8. PubMed ID: 616477 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]